A North Carolina Newborn Screening Pilot for Mucopolysaccharidosis II: Evaluating Endogenous Non-Reducing End Glycosaminoglycan Analysis and IDS Sequencing as Higher-Tier Testing Options
Summary
NBS for MPS II can be efficiently achieved with LC-MS/MS measuring I2S activity. The NRE GAG biomarker successfully differentiated between newborns with MPS II ...
Description
NBS for MPS II can be efficiently achieved with LC-MS/MS measuring I2S activity. The NRE GAG biomarker successfully differentiated between newborns with MPS II ...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source